Science & Enterprise subscription

Follow us on Twitter

  • Ooops ... https://t.co/G7nkwRtOS8
    about 3 hours ago
  • An international health coalition is funding development of vaccines against the new coronavirus outbreak spreading… https://t.co/6qO4xiglnc
    about 9 hours ago
  • New post on Science and Enterprise: Int’l Group Funding Coronavirus Vaccines https://t.co/lfGeJgppxy #Science #Business
    about 9 hours ago
  • A bio-compatible conduit is shown in tests with monkeys to promote regrowth of damaged nerve fibers, like those suf… https://t.co/Gqt6JkCEil
    about 14 hours ago
  • New post on Science and Enterprise: Implanted Guide Helps Regrow Damaged Body Nerves https://t.co/hlmKUMfNBI #Science #Business
    about 14 hours ago

Please share Science & Enterprise

Women Founders Again Raise Small Share of Venture Funds

Man, woman shaking hands

In 2019, only one in five new companies worldwide receiving venture financing was founded or co-founded by a woman, about the same percentage as in 2018. . . . → Read More: Women Founders Again Raise Small Share of Venture Funds

New Company Developing Cell-Based Milk

Milk splash

A biotechnology start-up enterprise plans to produce milk directly from mammary cells in the lab without crops, animals, or farms. . . . → Read More: New Company Developing Cell-Based Milk

Venture Deals, Dollars Fall in Q4 2019; Biotech Stays Hot

Global venture capital investing

Venture capital deal-making in the U.S. declined in the fourth quarter of 2019, but biotechnology start-ups remained the most sought-after investment targets of any sector. . . . → Read More: Venture Deals, Dollars Fall in Q4 2019; Biotech Stays Hot

UPMC to Invest $1 Billion in Medical Enterprises

UPMC lab

UPMC, the medical center affiliated with University of Pittsburgh, plans to invest $1 billion in life science advances, with spin-off companies as part of its strategy. . . . → Read More: UPMC to Invest $1 Billion in Medical Enterprises

New Biotech Aims to Bring Down Drug Prices

Pills on money

A biotechnology company launched yesterday that plans to discover and develop therapies faster and at lower cost than many of today’s new drugs. . . . → Read More: New Biotech Aims to Bring Down Drug Prices

Vaccine Developer Gains $11M in Early Funds

Baby with microcephaly

A company designing vaccines delivered with a microneedle patch to prevent infectious diseases is raising $11 million in its first venture funding round. . . . → Read More: Vaccine Developer Gains $11M in Early Funds

Infographic – Biotech Index Zooms to New High

NBI chart

Since October, the Nasdaq Biotechnology Index rose steadily to a new high for the year, as shown in this weekend’s infographic. . . . → Read More: Infographic – Biotech Index Zooms to New High

Commentary – New Models Needed for Antibiotic Resistance

MRSA bacteria

Many parts of a new model for fighting antibiotic resistance are in development, and the pieces still need to be assembled, but the outline of a precision-medicine rather than mass-produced drug model is beginning to emerge. . . . → Read More: Commentary – New Models Needed for Antibiotic Resistance

Touch Sensor Developer Gains $12M in Early Funds

HaptX glove

A company making gloves that transmit a sense of touch in games and commercial robotics is raising $12 million in its first venture funding round. . . . → Read More: Touch Sensor Developer Gains $12M in Early Funds

Duke Univ Forms Drug Development Company

Lab jars and beakers

Duke University and life science investor Deerfield Management are forming a new enterprise to develop drug candidates through early development stages. . . . → Read More: Duke Univ Forms Drug Development Company